Iovance Biotherapeutics, Inc. (IOVA) Insider Trading

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Jun 2025.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Jun 2025

Jun 5, 2025

Get an email when IOVA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 5, 2025	Daniel Gordon Kirby Chief Commercial Officer	Bought	30,000	$1.84	$55k	New	Form 4
May 23, 2025	Raj K. Puri Chief Regulatory Officer	Bought	5,600	$1.74	$10k	2.8%	Form 4
May 14, 2025	Frederick G Vogt Interim CEO & General Counsel	Bought	25,000	$1.69	$42k	7.2%	Form 4
Nov 12, 2024	Ryan D Maynard Director	SoldNo plan	50,000	$10.06	$503k	87%	Form 4

Jun 5, 2025
Daniel Gordon Kirby
Chief Commercial Officer · bought 30,000 at $1.84
$55k
New position
May 23, 2025
Raj K. Puri
Chief Regulatory Officer · bought 5,600 at $1.74
$10k
2.8% of stake
May 14, 2025
Frederick G Vogt
Interim CEO & General Counsel · bought 25,000 at $1.69
$42k
7.2% of stake
Nov 12, 2024No plan
Ryan D Maynard
Director · sold 50,000 at $10.06
$503k
87% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch IOVA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Biological Products, (No Diagnostic Substances)

DNLIDenali Therapeutics Inc.

ADPTAdaptive Biotechnologies Corporation

VCELVericel Corporation

VIRVir Biotechnology Inc.

MGTXMeiraGTx Holdings plc

VXRTVaxart Inc.

NVAXNovavax Inc.

IMCRImmunocore Holdings plc

Spot a number that looks wrong? Check it in IOVA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing IOVA

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.